DTaP-rHB-Hib vaccine (Yunnan Walvax Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameDTaP-rHB-Hib vaccine (Yunnan Walvax Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Toxoid vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWalvax Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsHepatitis BTetanusDiphtheria +[5]

Other Information

ATC CodeN/A